课题基金 / 基金详情

Development of local drug disposition analysis and delivery methods in human solid tumors

Development of local drug disposition analysis and delivery methods in human solid tumors
人类实体瘤局部药物分布分析和递送方法的开发
批准号:
12557212
负责人:
TAKAKURA Yoshinobu
金额:
$6.46万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

TAKAKURA Yoshinobu的其他基金

相似基金

相关文献

中文摘要
翻译
为了构建一种高效、安全的实体瘤体内给药系统,进行了一系列局部给药后的药代动力学研究。采用原位单次血管灌流技术,研究了第二代反义寡核苷酸在大鼠Walker 256肿瘤标本中的药代动力学。一些第一代寡核苷酸也用于比较。这些寡核苷酸通过两种方式直接注入肿瘤:持续动脉灌注和直接瘤内注射。提示该寡核苷酸可用于实体瘤的直接局部注射。另一方面,研究裸质粒DNA在荷瘤小鼠体内的药代动力学和基因表达。注射部位的质粒DNA被迅速清除,并观察到淋巴转移。将编码荧光素酶基因的裸质粒DNA注射到皮下接种的小鼠结肠癌中,可获得显著的基因表达。当同时注射特定的聚阴离子时,基因的表达被抑制,这表明在细胞摄取质粒DNA的过程中存在一种特定的机制。这些结果表明,肿瘤组织可能是直接转移裸质粒DNA的一个有前途的靶点。因此,本研究为基因药物,如反义寡核苷酸和质粒DNA在实体瘤中的基本处置特征提供了有用的信息。
英文摘要
To construct a strategy for developing efficient and safe in vivo drug delivery systems to solid tumors, a series of pharmacokinetic studies following local administration were carried out. The intratumoral pharmacokinetics of a second-generation antisense oligonucleotid were studied in rat Walker 256 tissue-isolated tumor preparations using an in situ single-pass vascular perfusion technique. Some first-generation oligonucleotides were also used for comparison. These oligonucleotides were administrated directly into the tumor in two ways : constant arterial infusion and direct intratumoral injection. The results suggested that the oligonucleotide may be useful for direct local injection into solid tumors. On the other hand, the intratumoral pharmacokinetics of naked plasmid DNA and gene expression were examined in mice bearing solid tumors. Plasmid DNA was rapidly eliminated from the injection site and lymphatic transfer was observed. Intratumoral injection of naked naked plasmid DNA encoding the luciferase gene into subcutaneously inoculated mouse colon tumor resulted in significant gene expression. The gene expression was inhibited when defined polyanions were injected simultaneously, implying the involvement of a specific mechanism in cellular uptake of plasmid DNA These results demonstrated that tumor tissue might be a promising target for direct gene transfer.with naked plasmid DNA. Thus, the present study provides useful information about the basic disposition characteristics of gene drugs, such as antisense oligonucleotides and plasmid DNA in solid tumors.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Yoshinobu Takakura: "Development of gene drug delivery systems based on pharmacokinetic studies"European Journal of Pharmaceutical Sciences. 13. 71-76 (2001)
Yoshinobu Takakura:“基于药代动力学研究的基因药物递送系统的开发”欧洲药物科学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshinobu Takakura: "Development of gene drug delivery systems based on pharmacokinetic studies"European Journal of Phamaceutical Sciences. 13. 71-76 (2001)
Yoshinobu Takakura:“基于药代动力学研究的基因药物递送系统的开发”欧洲药物科学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Optimization of cytokine gene therapy based on the regulation of transcription/translation, pharmacokinetics, and cellular response.
  • 批准号:
    24390008
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.9万
  • 财政年份:
    2012
  • 负责人:
    TAKAKURA Yoshinobu
  • 依托单位:
Design and delivery of plasmid vector for spatiotemporal control of the expression of therapeutic protein and siRNA
  • 批准号:
    21390009
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.73万
  • 财政年份:
    2009
  • 负责人:
    TAKAKURA Yoshinobu
  • 依托单位:
Development of all inclusive anti tumor immunotherapy based on engineered protein and nucleic acid
  • 批准号:
    19390041
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $12.31万
  • 财政年份:
    2007
  • 负责人:
    TAKAKURA Yoshinobu
  • 依托单位:
Design and delivery of nucleic acid drugs for optimization of DNA vaccination
  • 批准号:
    17390041
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $9.6万
  • 财政年份:
    2005
  • 负责人:
    TAKAKURA Yoshinobu
  • 依托单位:
海外基金